Cytiva
Cytiva, a prominent player in the life sciences sector, is headquartered in the United States and operates extensively across Europe and Asia. Founded in 2020, following the acquisition of GE Healthcare Life Sciences, Cytiva has quickly established itself as a leader in bioprocessing and biomanufacturing solutions. The company offers a diverse range of core products and services, including chromatography systems, cell culture media, and single-use technologies, all designed to enhance the efficiency and effectiveness of biopharmaceutical production. Cytiva's commitment to innovation and quality has positioned it as a trusted partner for researchers and manufacturers alike. With a strong market presence and a focus on advancing the development of life-saving therapies, Cytiva continues to achieve notable milestones in the industry, reinforcing its reputation as a vital contributor to the global health landscape.
DitchCarbon Score
How does Cytiva's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cytiva's score of 37 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cytiva's reported carbon emissions
In 2023, Cytiva reported total carbon emissions of approximately 64,913,000 kg CO2e, comprising 29,874,000 kg CO2e from Scope 1 and 35,045,000 kg CO2e from Scope 2. This marks a reduction from 2021, when total emissions were about 92,378,000 kg CO2e, with Scope 1 at 31,998,000 kg CO2e and Scope 2 at 60,380,000 kg CO2e. The company has not disclosed any Scope 3 emissions data. Cytiva's emissions have decreased significantly over the years, with a notable drop from 96,510,000 kg CO2e in 2019 to the current figures. However, the company has not set specific reduction targets or climate pledges, indicating a potential area for future commitment. As a leader in the life sciences industry, Cytiva's ongoing efforts to manage and reduce its carbon footprint are crucial in the context of global climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 27,681,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 68,829,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cytiva is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
